Date & Time
Tuesday, July 20, 2021, 9:00 AM - 10:00 AM
9:00 AM - 10:00 AM
P01 Opening Session: Schizophrenia Treatment, Management and Reentry - Sponsored by an independent educational grant from Alkermes

Schizophrenia is overrepresented in the criminal justice system, particularly in correctional facilities, with prevalence estimated at 2% to 6.5% in state prison inmates vs. 1.1% in the U.S. adult population. Individuals with schizophrenia may be more resistant to medication as the delusions, hallucinations, and disturbed thinking make it difficult for them to realize that they have a mental illness. Unfortunately, these individuals have a hard time in corrections, ending up with longer sentences as they are unable to comply with instructions and rules. 

Join us for a discussion of treatment options that are long-lasting, easy to administer, and do not rely on daily compliance. Find solutions to help individuals establish control over their behaviors and have more success when they leave correctional facilities.

Learning Objectives

  • Summarize relevant treatment guidelines for incarcerated individuals with schizophrenia
  • Describe barriers to schizophrenia treatment¬†
  • Discuss future directions in schizophrenia treatment



Mental Health